(FUL) H Fuller - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3596941068

Adhesives, Sealants, Coatings, Chemical Products, Tapes

FUL EPS (Earnings per Share)

EPS (Earnings per Share) of FUL over the last years for every Quarter: "2020-08": 0.76, "2020-11": 1.06, "2021-02": 0.66, "2021-05": 0.94, "2021-08": 0.78, "2021-11": 1.09, "2022-02": 0.8, "2022-05": 1.11, "2022-08": 1.06, "2022-11": 1.04, "2023-02": 0.55, "2023-05": 0.93, "2023-08": 1.06, "2023-11": 1.32, "2024-02": 0.67, "2024-05": 1.12, "2024-08": 1.13, "2024-11": 0.92, "2025-02": 0.54, "2025-05": 1.18, "2025-08": 1.26,

FUL Revenue

Revenue of FUL over the last years for every Quarter: 2020-08: 691.463, 2020-11: 777.64, 2021-02: 725.904, 2021-05: 827.873, 2021-08: 826.83, 2021-11: 897.424, 2022-02: 856.482, 2022-05: 993.258, 2022-08: 941.23, 2022-11: 958.213, 2023-02: 809.183, 2023-05: 898.239, 2023-08: 900.634, 2023-11: 902.879, 2024-02: 810.419, 2024-05: 917.107, 2024-08: 917.927, 2024-11: 923.284, 2025-02: 788.663, 2025-05: 898.095, 2025-08: 892.043,

Description: FUL H Fuller

H.B. Fuller Company is a leading global manufacturer of adhesives, sealants, and specialty chemicals, operating through three main segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The companys diverse product portfolio caters to various industries, including packaging, nonwoven, healthcare, automotive, electronics, and construction.

The companys business segments demonstrate a strong presence in the global market, with Hygiene, Health and Consumable Adhesives serving the packaging and hygiene industries, Engineering Adhesives targeting high-performance applications in durable assembly and transportation, and Construction Adhesives providing products for tile setting, roofing, and insulation. H.B. Fuller Companys products are sold directly to customers, as well as through distributors and retailers across multiple regions, including North America, Latin America, Europe, and Asia Pacific.

To evaluate the companys performance, key performance indicators (KPIs) such as revenue growth, gross margin ratio, and operating cash flow margin can be analyzed. A review of the companys financials reveals that its revenue has been steadily increasing, driven by a combination of organic growth and strategic acquisitions. The gross margin ratio has remained relatively stable, indicating the companys ability to maintain its pricing power and manage raw material costs. Additionally, the operating cash flow margin has been improving, suggesting effective cost management and operational efficiency.

Further analysis of H.B. Fuller Companys financials and industry trends reveals opportunities for growth in emerging markets, driven by increasing demand for specialty adhesives and sealants. The companys commitment to innovation and R&D has enabled it to stay ahead of the competition, with a strong pipeline of new products and technologies. As a Trading Analyst, it is essential to monitor the companys progress in executing its growth strategy and adjusting to changing market conditions.

FUL Stock Overview

Market Cap in USD 3,191m
Sub-Industry Specialty Chemicals
IPO / Inception 1990-03-26

FUL Stock Ratings

Growth Rating -20.0%
Fundamental 50.2%
Dividend Rating 59.3%
Return 12m vs S&P 500 -35.1%
Analyst Rating 3.50 of 5

FUL Dividends

Dividend Yield 12m 1.58%
Yield on Cost 5y 2.02%
Annual Growth 5y 7.73%
Payout Consistency 97.0%
Payout Ratio 23.8%

FUL Growth Ratios

Growth Correlation 3m 14.6%
Growth Correlation 12m -43.4%
Growth Correlation 5y 23.2%
CAGR 5y -2.11%
CAGR/Max DD 3y (Calmar Ratio) -0.05
CAGR/Mean DD 3y (Pain Ratio) -0.14
Sharpe Ratio 12m -1.68
Alpha -42.30
Beta 1.125
Volatility 27.76%
Current Volume 226.9k
Average Volume 20d 388.7k
Stop Loss 57 (-3.1%)
Signal -0.01

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (114.9m TTM) > 0 and > 6% of Revenue (6% = 210.1m TTM)
FCFTA 0.02 (>2.0%) and ΔFCFTA -2.79pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 17.89% (prev 17.62%; Δ 0.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.05 (>3.0%) and CFO 242.4m > Net Income 114.9m (YES >=105%, WARN >=100%)
Net Debt (1.96b) to EBITDA (487.0m) ratio: 4.02 <= 3.0 (WARN <= 3.5)
Current Ratio 1.93 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (55.4m) change vs 12m ago -2.24% (target <= -2.0% for YES)
Gross Margin 30.54% (prev 30.48%; Δ 0.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 69.05% (prev 71.28%; Δ -2.23pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 2.30 (EBITDA TTM 487.0m / Interest Expense TTM 134.2m) >= 6 (WARN >= 3)

Altman Z'' 3.02

(A) 0.12 = (Total Current Assets 1.30b - Total Current Liabilities 674.2m) / Total Assets 5.17b
(B) 0.39 = Retained Earnings (Balance) 2.01b / Total Assets 5.17b
(C) 0.06 = EBIT TTM 308.4m / Avg Total Assets 5.07b
(D) 0.52 = Book Value of Equity 1.67b / Total Liabilities 3.21b
Total Rating: 3.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 50.21

1. Piotroski 3.50pt = -1.50
2. FCF Yield 2.36% = 1.18
3. FCF Margin 3.47% = 0.87
4. Debt/Equity 1.06 = 1.96
5. Debt/Ebitda 4.02 = -2.50
6. ROIC - WACC (= -0.42)% = -0.52
7. RoE 6.18% = 0.51
8. Rev. Trend -9.55% = -0.72
9. EPS Trend 18.41% = 0.92

What is the price of FUL shares?

As of October 18, 2025, the stock is trading at USD 58.81 with a total of 226,946 shares traded.
Over the past week, the price has changed by +3.42%, over one month by -2.78%, over three months by -3.11% and over the past year by -25.09%.

Is H Fuller a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, H Fuller is currently (October 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 50.21 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FUL is around 53.10 USD . This means that FUL is currently overvalued and has a potential downside of -9.71%.

Is FUL a buy, sell or hold?

H Fuller has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold FUL.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 3
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the FUL price?

Issuer Target Up/Down from current
Wallstreet Target Price 68.8 17%
Analysts Target Price 68.8 17%
ValueRay Target Price 58.2 -1%

Last update: 2025-10-08 02:24

FUL Fundamental Data Overview

Market Cap USD = 3.19b (3.19b USD * 1.0 USD.USD)
P/E Trailing = 28.3654
P/E Forward = 12.6103
P/S = 0.9112
P/B = 1.6335
P/EG = 2.2309
Beta = 1.125
Revenue TTM = 3.50b USD
EBIT TTM = 308.4m USD
EBITDA TTM = 487.0m USD
Long Term Debt = 2.08b USD (from longTermDebt, last quarter)
Short Term Debt = 16.0m USD (from shortTermDebt, last fiscal year)
Debt = 2.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.96b USD (from netDebt column, last quarter)
Enterprise Value = 5.15b USD (3.19b + Debt 2.08b - CCE 122.5m)
Interest Coverage Ratio = 2.30 (Ebit TTM 308.4m / Interest Expense TTM 134.2m)
FCF Yield = 2.36% (FCF TTM 121.4m / Enterprise Value 5.15b)
FCF Margin = 3.47% (FCF TTM 121.4m / Revenue TTM 3.50b)
Net Margin = 3.28% (Net Income TTM 114.9m / Revenue TTM 3.50b)
Gross Margin = 30.54% ((Revenue TTM 3.50b - Cost of Revenue TTM 2.43b) / Revenue TTM)
Gross Margin QoQ = 31.96% (prev 31.89%)
Tobins Q-Ratio = 1.00 (Enterprise Value 5.15b / Total Assets 5.17b)
Interest Expense / Debt = 1.62% (Interest Expense 33.6m / Debt 2.08b)
Taxrate = 19.93% (16.5m / 82.9m)
NOPAT = 247.0m (EBIT 308.4m * (1 - 19.93%))
Current Ratio = 1.93 (Total Current Assets 1.30b / Total Current Liabilities 674.2m)
Debt / Equity = 1.06 (Debt 2.08b / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 4.02 (Net Debt 1.96b / EBITDA 487.0m)
Debt / FCF = 16.13 (Net Debt 1.96b / FCF TTM 121.4m)
Total Stockholder Equity = 1.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.22% (Net Income 114.9m / Total Assets 5.17b)
RoE = 6.18% (Net Income TTM 114.9m / Total Stockholder Equity 1.86b)
RoCE = 7.83% (EBIT 308.4m / Capital Employed (Equity 1.86b + L.T.Debt 2.08b))
RoIC = 6.24% (NOPAT 247.0m / Invested Capital 3.96b)
WACC = 6.66% (E(3.19b)/V(5.27b) * Re(10.16%) + D(2.08b)/V(5.27b) * Rd(1.62%) * (1-Tc(0.20)))
Discount Rate = 10.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.70%
[DCF Debug] Terminal Value 70.89% ; FCFE base≈175.3m ; Y1≈174.9m ; Y5≈184.8m
Fair Price DCF = 42.74 (DCF Value 2.31b / Shares Outstanding 54.1m; 5y FCF grow -0.83% → 3.0% )
EPS Correlation: 18.41 | EPS CAGR: 7.23% | SUE: 0.07 | # QB: 0
Revenue Correlation: -9.55 | Revenue CAGR: -2.57% | SUE: -0.01 | # QB: 0

Additional Sources for FUL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle